Cardote Teresa A F, Ciulli Alessio
Biological Chemistry and Drug Discovery Division, School of Life Sciences, University of Dundee, Dow Street, DD1 5EH, Dundee, UK.
ChemMedChem. 2017 Sep 21;12(18):1491-1496. doi: 10.1002/cmdc.201700359. Epub 2017 Sep 1.
Cullin RING E3 ubiquitin ligases (CRLs) are large dynamic multi-subunit complexes that control the fate of many proteins in cells. CRLs are attractive drug targets for the development of small-molecule inhibitors and chemical inducers of protein degradation. Herein we describe a structure-guided biophysical approach to probe the protein-protein interaction (PPI) between the Cullin-2 scaffold protein and the adaptor subunits Elongin BC within the context of the von Hippel-Lindau complex (CRL2 ) using peptides. Two peptides were shown to bind at the targeted binding site on Elongin C, named the "EloC site", with micromolar dissociation constants, providing a starting point for future optimization. Our results suggest ligandability of the EloC binding site to short linear peptides, unveiling the opportunity and challenges to develop small molecules that have the potential to target selectively the Cul2-adaptor PPI within CRLs.
Cullin环E3泛素连接酶(CRLs)是大型动态多亚基复合物,可控制细胞中许多蛋白质的命运。CRLs是开发小分子抑制剂和蛋白质降解化学诱导剂的有吸引力的药物靶点。在此,我们描述了一种基于结构的生物物理方法,利用肽在冯·希佩尔-林道复合物(CRL2)的背景下探测Cullin-2支架蛋白与衔接子亚基Elongin BC之间的蛋白质-蛋白质相互作用(PPI)。两种肽被证明以微摩尔解离常数结合在Elongin C上的靶向结合位点,即“EloC位点”,为未来的优化提供了一个起点。我们的结果表明EloC结合位点对短线性肽具有配体性,揭示了开发有可能在CRLs中选择性靶向Cul2-衔接子PPI的小分子的机遇和挑战。